相关实验视频
Updated: Jul 15, 2025

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.2K
患有炎症性肠道疾病的患者中痛风的患病率增加:一个基于人口的研究
Osama Hamid1, Khaled Alsabbagh Alchirazi1, Ahmed Eltelbany1
1Department of Hospital Medicine Cleveland Clinic Cleveland Ohio USA.
JGH open : an open access journal of gastroenterology and hepatology
|September 25, 2023
概括
炎症性肠病 (IBD) 与高风险的痛风有关,特别是克罗恩病. 肠切除进一步增加了这种风险,需要在IBD患者中进行痛风检查.
科学领域:
- 胃肠病学 胃肠病学
- 类风湿病学 类风湿病学
- 流行病学 流行病学
背景情况:
- 关节炎是已知的炎症性肠病 (IBD) 的肠外表现.
- 在IBD患者中观察到尿酸代谢的改变.
- IBD和痛风之间的关系需要进一步调查.
研究的目的:
- 调查炎症性肠病 (IBD) 和痛风之间的关联.
- 确定特定类型的IBD (克罗恩病和性结肠炎) 与痛风有不同的关联.
- 探索肠切除对IBD患者痛风风险的影响.
主要方法:
- 从1999年到2022年使用了多中心的美国医疗保健数据库 (Explorys Inc.)
- 确定的成年患者被诊断患有克罗恩病 (CD) 和性结肠炎 (UC).
- 使用多变量分析分析人口统计数据,IBD相关的关节炎,肠切除和痛风诊断.
主要成果:
- 在CD和痛风 (OR 1.68) 和UC和痛风 (OR 1.38) 之间发现了显著的关联.
- 痛风的患病率在UC患者中为4.3%,在CD患者中为5.61%.
- 肠切除与CD (OR 2.34) 和UC (OR 1.53) 患者的痛风风险增加有关.
结论:
- 炎症性肠病 (IBD) 与痛风有很强的联系.
- 克罗恩氏病与痛风的相关性比性结肠炎更高.
- 患有IBD和新发性关节炎的患者应对痛风进行评估,特别是如果他们经历了肠切除.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
279
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
279
Inflammatory Bowel Disease I: Ulcerative Colitis
207
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
207
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
348
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
348
Chronic Bowel Disorders: Introduction
474
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
474
Inflammatory Bowel Disease IV: Pharmacological Management
145
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
145
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
144
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
144

